Epidemiology of type 1 and type 2 diabetes mellitus in Kazakhstan: data from unified National Electronic Health System 2014–2019

Abstract Background We aimed to explore descriptive epidemiology of T1 and T2 Diabetes Mellitus (DM) and to investigate demographic factors and comorbidities associated with all-cause mortality by aggregating and utilizing large-scale administrative healthcare data from the Unified National Electron...

Full description

Bibliographic Details
Main Authors: Dinara Galiyeva, Arnur Gusmanov, Yesbolat Sakko, Alpamys Issanov, Kuralay Atageldiyeva, Kainar Kadyrzhanuly, Aiymzhan Nurpeissova, Marzhan Rakhimzhanova, Aigul Durmanova, Antonio Sarria-Santamera, Abduzhappar Gaipov
Format: Article
Language:English
Published: BMC 2022-11-01
Series:BMC Endocrine Disorders
Subjects:
Online Access:https://doi.org/10.1186/s12902-022-01200-6
_version_ 1811230613338849280
author Dinara Galiyeva
Arnur Gusmanov
Yesbolat Sakko
Alpamys Issanov
Kuralay Atageldiyeva
Kainar Kadyrzhanuly
Aiymzhan Nurpeissova
Marzhan Rakhimzhanova
Aigul Durmanova
Antonio Sarria-Santamera
Abduzhappar Gaipov
author_facet Dinara Galiyeva
Arnur Gusmanov
Yesbolat Sakko
Alpamys Issanov
Kuralay Atageldiyeva
Kainar Kadyrzhanuly
Aiymzhan Nurpeissova
Marzhan Rakhimzhanova
Aigul Durmanova
Antonio Sarria-Santamera
Abduzhappar Gaipov
author_sort Dinara Galiyeva
collection DOAJ
description Abstract Background We aimed to explore descriptive epidemiology of T1 and T2 Diabetes Mellitus (DM) and to investigate demographic factors and comorbidities associated with all-cause mortality by aggregating and utilizing large-scale administrative healthcare data from the Unified National Electronic Health System (UNEHS) of Kazakhstan for 2014–2019 years period. Methods A total of 475,539 individuals were included in the analyses. The median years of follow-up for Type 1 DM patients accounted for 4.7 years and 4.5 years in Type 2 DM patients. We used Kaplan-Meier and log-rank test to calculate failure function and differences in survival by age, sex, ethnicity, and comorbidities with all-cause mortality for Type 1 and Type 2 DM. Cox proportional hazards regression analysis was used to obtain crude and adjusted hazard ratios. Results Prevalence of Type 1 and Type 2 DM increased 1.7 times from 2014 to 2019. Mortality of Type 1 and Type 2 DM also increased 4 times and 6 times from 2014 to 2019, respectively. Male sex, older age and Kazakh ethnicity were associated with a higher risk of all-cause death compared to females, younger age and other nationalities than Kazakh in patients with Type 1 and Type 2 DM. Coronary artery disease, diabetic nephropathy, stroke, amputations and neoplasms were associated with a higher risk of all-cause death. Conclusion The prevalence and mortality rate of Type 1 and Type 2 DM increased during the years 2014–2019 in Kazakhstan. Male sex, older age and Kazakh ethnicity were associated with a higher risk of all-cause death compared to females, younger age and other nationalities than Kazakh. Coronary artery disease, diabetic nephropathy, stroke, amputations and neoplasms were associated with a higher risk of all-cause death.
first_indexed 2024-04-12T10:31:36Z
format Article
id doaj.art-75a8ad1eef5f4d5ab35278fc1763888d
institution Directory Open Access Journal
issn 1472-6823
language English
last_indexed 2024-04-12T10:31:36Z
publishDate 2022-11-01
publisher BMC
record_format Article
series BMC Endocrine Disorders
spelling doaj.art-75a8ad1eef5f4d5ab35278fc1763888d2022-12-22T03:36:50ZengBMCBMC Endocrine Disorders1472-68232022-11-0122111010.1186/s12902-022-01200-6Epidemiology of type 1 and type 2 diabetes mellitus in Kazakhstan: data from unified National Electronic Health System 2014–2019Dinara Galiyeva0Arnur Gusmanov1Yesbolat Sakko2Alpamys Issanov3Kuralay Atageldiyeva4Kainar Kadyrzhanuly5Aiymzhan Nurpeissova6Marzhan Rakhimzhanova7Aigul Durmanova8Antonio Sarria-Santamera9Abduzhappar Gaipov10Department of Medicine, School of Medicine, Nazarbayev UniversityDepartment of Medicine, School of Medicine, Nazarbayev UniversityDepartment of Medicine, School of Medicine, Nazarbayev UniversityDepartment of Medicine, School of Medicine, Nazarbayev UniversityDepartment of Medicine, School of Medicine, Nazarbayev UniversityDepartment of Medicine, School of Medicine, Nazarbayev UniversityDepartment of Medical Information Analysis of Outpatient and Polyclinic Care, Republican Center of Electronic HealthcareClinical Academic Department of Pediatrics, University Medical CenterClinical Academic Department of Internal Medicine, University Medical CenterDepartment of Medicine, School of Medicine, Nazarbayev UniversityDepartment of Medicine, School of Medicine, Nazarbayev UniversityAbstract Background We aimed to explore descriptive epidemiology of T1 and T2 Diabetes Mellitus (DM) and to investigate demographic factors and comorbidities associated with all-cause mortality by aggregating and utilizing large-scale administrative healthcare data from the Unified National Electronic Health System (UNEHS) of Kazakhstan for 2014–2019 years period. Methods A total of 475,539 individuals were included in the analyses. The median years of follow-up for Type 1 DM patients accounted for 4.7 years and 4.5 years in Type 2 DM patients. We used Kaplan-Meier and log-rank test to calculate failure function and differences in survival by age, sex, ethnicity, and comorbidities with all-cause mortality for Type 1 and Type 2 DM. Cox proportional hazards regression analysis was used to obtain crude and adjusted hazard ratios. Results Prevalence of Type 1 and Type 2 DM increased 1.7 times from 2014 to 2019. Mortality of Type 1 and Type 2 DM also increased 4 times and 6 times from 2014 to 2019, respectively. Male sex, older age and Kazakh ethnicity were associated with a higher risk of all-cause death compared to females, younger age and other nationalities than Kazakh in patients with Type 1 and Type 2 DM. Coronary artery disease, diabetic nephropathy, stroke, amputations and neoplasms were associated with a higher risk of all-cause death. Conclusion The prevalence and mortality rate of Type 1 and Type 2 DM increased during the years 2014–2019 in Kazakhstan. Male sex, older age and Kazakh ethnicity were associated with a higher risk of all-cause death compared to females, younger age and other nationalities than Kazakh. Coronary artery disease, diabetic nephropathy, stroke, amputations and neoplasms were associated with a higher risk of all-cause death.https://doi.org/10.1186/s12902-022-01200-6DiabetesSurvivalMortalityEpidemiologyComorbidities
spellingShingle Dinara Galiyeva
Arnur Gusmanov
Yesbolat Sakko
Alpamys Issanov
Kuralay Atageldiyeva
Kainar Kadyrzhanuly
Aiymzhan Nurpeissova
Marzhan Rakhimzhanova
Aigul Durmanova
Antonio Sarria-Santamera
Abduzhappar Gaipov
Epidemiology of type 1 and type 2 diabetes mellitus in Kazakhstan: data from unified National Electronic Health System 2014–2019
BMC Endocrine Disorders
Diabetes
Survival
Mortality
Epidemiology
Comorbidities
title Epidemiology of type 1 and type 2 diabetes mellitus in Kazakhstan: data from unified National Electronic Health System 2014–2019
title_full Epidemiology of type 1 and type 2 diabetes mellitus in Kazakhstan: data from unified National Electronic Health System 2014–2019
title_fullStr Epidemiology of type 1 and type 2 diabetes mellitus in Kazakhstan: data from unified National Electronic Health System 2014–2019
title_full_unstemmed Epidemiology of type 1 and type 2 diabetes mellitus in Kazakhstan: data from unified National Electronic Health System 2014–2019
title_short Epidemiology of type 1 and type 2 diabetes mellitus in Kazakhstan: data from unified National Electronic Health System 2014–2019
title_sort epidemiology of type 1 and type 2 diabetes mellitus in kazakhstan data from unified national electronic health system 2014 2019
topic Diabetes
Survival
Mortality
Epidemiology
Comorbidities
url https://doi.org/10.1186/s12902-022-01200-6
work_keys_str_mv AT dinaragaliyeva epidemiologyoftype1andtype2diabetesmellitusinkazakhstandatafromunifiednationalelectronichealthsystem20142019
AT arnurgusmanov epidemiologyoftype1andtype2diabetesmellitusinkazakhstandatafromunifiednationalelectronichealthsystem20142019
AT yesbolatsakko epidemiologyoftype1andtype2diabetesmellitusinkazakhstandatafromunifiednationalelectronichealthsystem20142019
AT alpamysissanov epidemiologyoftype1andtype2diabetesmellitusinkazakhstandatafromunifiednationalelectronichealthsystem20142019
AT kuralayatageldiyeva epidemiologyoftype1andtype2diabetesmellitusinkazakhstandatafromunifiednationalelectronichealthsystem20142019
AT kainarkadyrzhanuly epidemiologyoftype1andtype2diabetesmellitusinkazakhstandatafromunifiednationalelectronichealthsystem20142019
AT aiymzhannurpeissova epidemiologyoftype1andtype2diabetesmellitusinkazakhstandatafromunifiednationalelectronichealthsystem20142019
AT marzhanrakhimzhanova epidemiologyoftype1andtype2diabetesmellitusinkazakhstandatafromunifiednationalelectronichealthsystem20142019
AT aiguldurmanova epidemiologyoftype1andtype2diabetesmellitusinkazakhstandatafromunifiednationalelectronichealthsystem20142019
AT antoniosarriasantamera epidemiologyoftype1andtype2diabetesmellitusinkazakhstandatafromunifiednationalelectronichealthsystem20142019
AT abduzhappargaipov epidemiologyoftype1andtype2diabetesmellitusinkazakhstandatafromunifiednationalelectronichealthsystem20142019